GlassScriptPhysician profile
Ashley N Lopresto
NPI 1548658644
$5,034.73
in general payments reported to CMS, 2019-2025
37 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,082 · 2022: $1,299 · 2023: $725 · 2024: $496 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $969.88 | 2021-2025 | |
| Novo Nordisk INC | $748.74 | 2021-2024 | Wegovy, Saxenda, Rybelsus |
| Lilly USA, LLC | $453.39 | 2021-2024 | Mounjaro, Zepbound, Emgality |
| Amgen INC. | $332.71 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $277.43 | 2021-2023 | Austedo, Austedo Xr |
| Janssen Pharmaceuticals, INC | $262.86 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $208.20 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $199.19 | 2022-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.83 | 2021-2024 | Jardiance, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $168.13 | 2021-2025 | Airsupra, Farxiga |
| Pfizer INC. | $167.99 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $114.47 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $93.51 | 2022-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $78.06 | 2022 | |
| Mylan Specialty L.P. | $64.24 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $60.08 | 2021-2022 | |
| Lundbeck LLC | $59.52 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $58.33 | 2021-2025 | |
| Bioventus LLC | $51.24 | 2021 | |
| Dynasplint Systems INC. | $50.78 | 2022 | |
| Axsome Therapeutics, INC. | $47.30 | 2023-2025 | Auvelity |
| Glaxosmithkline, LLC. | $39.55 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.36 | 2022 | |
| Arbor Pharmaceuticals, INC. | $28.26 | 2021 | |
| Radius Health, INC. | $27.83 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.66 | 2021 | |
| Daiichi Sankyo INC. | $27.63 | 2021 | |
| Amarin Pharma, INC. | $27.36 | 2021 | |
| Dexcom, INC. | $23.09 | 2021 | |
| Orthofix Medical, INC. | $21.04 | 2021 | |
| Eisai INC. | $20.31 | 2022 | |
| Pacira Therapeutics, INC. | $18.27 | 2021 | |
| Astellas Pharma US INC | $17.67 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.45 | 2022 | |
| Neurocrine Biosciences, INC. | $16.11 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.05 | 2021 | |
| Exact Sciences Corporation | $13.21 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lopresto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.